it's foundational
Ro indica que hay poca prueba de que funcionen para bajar de peso
However, subsequent CV outcome trials with alogliptin, saxagliptin, and sitagliptin showed noninferiority but failed to demonstrate any superiority compared with placebo in patients with type 2 diabetes mellitus and high CV risk
Meyers, D
As part of our ongoing commitment to people with type 2 diabetes, we are also expanding our efforts to educate the public on the link between cardiovascular disease and type 2 diabetes. In 2014, JARDIANCE was approved by the FDA as an adjunct to diet and exercise to improve glycemic control, or blood glucose levels, in adults with type 2 diabetes
Abordaje de factores contribuyentes: Evaluar y tratar condiciones coexistentes que dificultan la prdida de peso: resistencia a la insulina, sndrome de ovario poliqustico, apnea del sueo, deficiencia de vitamina D (comn en Hashimoto) y trastornos del estado de nimo